◆ 会议时间：2025年10月16-18日
◆ 会议地点：加拿大 蒙特利尔

◆ 会议简介：

2025年加拿大成瘾医学协会(CSAM-SMCA)科学大会与年会将于2025年10月16-18日在加拿大蒙特利尔举行。

加拿大成瘾医学协会(CSAM-SCMA)成立于1989年，是一个由医学专业人士和其他对物质使用障碍领域感兴趣的科学家组成的全国性组织。CSAM为专业人员和公众提供了有关成瘾的科学和医学信息资源，促进对成瘾医学的了解、评估、治疗、预防和研究。CSAM的成员包括医生以及来自不同学科的健康专业人士，如药剂师、护士、社会工作者和治疗师等等。未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网-lingyuint.com）

CSAM-SMCA 2025 - Scientific Conference and Annual Meeting of the Canadian Society of Addiction Medicine (CSAM-SMCA)

Date: October 16-18, 2025
Venue: Montreal, Quebec, Canada

Organized by:
Canadian Society of Addiction Medicine (CSAM)
La Société canadienne de médecine de l’addiction (SMMA)

The CSAM-SMCA 2025 Scientific Conference is Canada’s premier education and networking event for addiction medicine practitioners. This annual event brings together researchers, leaders, educators, and clinicians in addiction medicine for three days of learning and networking. Our objective is to present new scientific research and best practices in addiction medicine, promote evidence-based care, and encourage the sharing of diverse perspectives on addiction treatment and recovery.

摘要征文投稿：

Call for Abstracts

Submission deadline is April 6.

点此提交摘要>>>Submit Abstract>>>

Submission Guidelines

• Please use non-stigmatizing language, generic pharmaceutical names, and a minimum of abbreviations.
• All abstract submissions should be a maximum of 300 words.
• Oral or poster presentation abstracts describing a research study must be structured with the following headings:
  Introduction/Background: Briefly describe the context or background of the study, including the research question or problem being addressed.
  Methods: Explain the methodology used, including study design, data collection, and analysis methods.
  Results: Highlight the key findings or outcomes of your work.
  Conclusion: Summarize the implications of the results, and if applicable, suggest potential future research or recommendations.
• Abstracts can be submitted in English or French. Abstracts must present material in a clear manner with grammar and spelling of a quality suitable for publication. Presentations will be in the language of the abstract.
• Abstracts and presentations must be free of commercial bias and cannot be used to advertise or advocate for a specific commercial interest.
• Each abstract submission must include two clear learning objectives. These objectives should outline the key takeaways for participants and reflect the content and purpose of the research or presentation. Please make sure that the learning objectives are formatted correctly. For guidance, please refer to this link.
• Lead Authors must agree to follow the CSAM-SMCA guidelines for abstracts before submitting an abstract.
• A signed Conflict of Interest form for EVERY author must be uploaded with the abstract submission. Abstracts without the disclosure statements will be declined.
• Disclosure Slide: a disclosure slide is required for each oral presentation. Having a financial disclosure will NOT preclude the acceptance of an abstract.
• After submitting an abstract, the Lead Author will receive a confirmation email. If you do not receive the confirmation email within 24 hours, please contact conference@csam-smca.org.
• Publication: Select conference abstracts may be published in the Canadian Journal of Addiction.
• CSAM-SMCA has permission to use the abstracts submitted, accepted and the presentations of these abstracts for educational and marketing purposes by the CSAM-SMCA.
• Abstracts included in the conference proceedings will be available through the conference app.
• Abstracts accepted for in-person presentation MUST be delivered in person.
• Presentations that are recorded during the conference will be uploaded to the app when available for on-demand viewing. CSAM-SMCA has permission to use these videos for educational and marketing purposes by CSAM-SMCA.
• Please do not submit an abstract if you are not confident that you will be able to give the presentation. Cancellations impose a serious burden on the development of the conference program and may negatively impact the overall quality of the program. If extenuating circumstances prevent the attendance of a presenter, please notify conference@csam-smca.org as soon as possible so the presentation can be removed from the program.
• Abstracts will be evaluated by members of the Scientific Conference Committee. Decisions of the Scientific Conference Committee are final.
• Decisions regarding abstracts will be completed by April 30, 2025.
• Abstracts that are accepted:
  • Acceptance emails will be sent by May 16, 2025 to the Lead Author.
  • Once the Lead Author has accepted to present, they will receive an email with the date and time of their presentation by June 30, 2025.
  • All presenters must register for the conference and pay the registration fee before their presentation is finalized in the program.
• Abstracts that are not accepted:
  • The Lead Author will receive an email.
  • Decisions of the Conference Committee are final.
• Correspondence will only be with the Lead Author, who must notify any co-authors. The Scientific Conference Committee is not responsible for notification emails not received due to incorrect contact information.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。